News

Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.
In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...
George W. Bush’s program to fight HIV and AIDS in Africa has been credited with saving millions of lives. The Trump ...
South Africa National Assembly Speaker Thoko Didiza on June 17 swore in lesbian feminist Palomino Jama as a new MP.
As South Africa is buffeted by criticism from President Donald Trump and other American conservatives—some of it unfair and ...
The Global Fund to Fight AIDS, TB and malaria (Global Fund) has notified Health Minister Aaron Motsoaledi that it will reduce funding to South Africa by R1.4-billion.
Professor Francois Venter refuses to pull his punches, and he has publicly excoriated both the President and the health ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher infection ...
South Africa’s HIV programme is the biggest in the world, but now it’s been cut thin, with the loss of billions in US funding ...
Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...
According to the UNAIDS Spectrum Report 2024, approximately 360,000 people are currently living with HIV in Botswana.